International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists · 1996
p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schammel D P, Bocklage T
Аннотация
Sixty molar and nonmolar placentas with hydropic features [23 complete moles, 14 partial moles, 8 moles-not further classified, and 15 hydropic, nonmolar placentas] were evaluated immunohistochemically for expression of Ki-67, proliferating cell nuclear antigen (PCNA), and p53, and the results were compared with DNA ploidy and S-phase fractions derived from flow cytometric analysis. The data were evaluated to determine if proliferation marker staining could aid in distinguishing mole from non-mole and partial from complete mole. PCNA and p53 expression did not discriminate between moles and non-moles. However, the percentage of rimming villous cytotrophoblast nuclei reactive for Ki-67 differed significantly between moles and non-moles (p < 0.001). All molar specimens contained at least one medium-sized villus with > 70% Ki-67-positive cells, whereas the maximum percentage of reactive cells in hydropic abortuses was 22%. These results suggest that percentage Ki-67 positivity in rimming cytotrophoblast nuclei may aid in distinguishing a mole from a nonmolar, hydropic abortion.
Предметные рубрики MeSH
AdolescentAdultBiomarkers, TumorCell DivisionChorionic Gonadotropin, beta Subunit, HumanDNA, NeoplasmFemaleFlow CytometryHumansHydatidiform MoleImmunohistochemistryKi-67 AntigenMaternal AgeNeoplasm ProteinsNuclear ProteinsPloidiesPregnancyProliferating Cell Nuclear AntigenRetrospective StudiesTumor Suppressor Protein p53Uterine Neoplasms